Detalles de la búsqueda
1.
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
Haematologica
; 108(6): 1567-1578, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36727397
2.
Patient and Caregiver Insights into the Disease Burden of Myelodysplastic Syndrome.
Patient Relat Outcome Meas
; 13: 31-38, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35153520
3.
Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.
Leuk Lymphoma
; 62(6): 1411-1421, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33430673
4.
Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates.
Leuk Lymphoma
; 62(7): 1730-1739, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33648418
5.
Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.
J Med Econ
; 24(1): 234-243, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33472483
6.
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
Leukemia
; 35(12): 3455-3465, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34017073
7.
MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
Cancer Med
; 9(13): 4512-4526, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32351024
8.
Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
Leukemia
; 35(12): 3626, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34475521
Resultados
1 -
8
de 8
1
Próxima >
>>